SLU-PP-332
5mg
⚠️ Not for human consumption. Research purposes only.
Description
SLU-PP-332 is a small molecule ERR (estrogen-related receptor) agonist developed at Saint Louis University. It has been studied in preclinical animal models for its effects on skeletal muscle fiber-type switching, mitochondrial biogenesis, and oxidative metabolism pathways, mimicking transcriptional changes associated with endurance exercise.
Key Areas of Study
- ERR agonist signaling research
- muscle fiber-type switching studies
- mitochondrial biogenesis analysis
- exercise-mimetic pathway modeling
Mechanisms Being Evaluated
SLU-PP-332 activates ERRα, ERRβ, and ERRγ transcription factors, which regulate the expression of genes involved in oxidative phosphorylation, fatty acid oxidation, and mitochondrial biogenesis. Preclinical studies have demonstrated increased type I muscle fiber composition in treated animal models.
Commonly Researched Uses
Estrogen-related receptor signaling research, exercise-mimetic compound studies, mitochondrial biogenesis investigations, skeletal muscle metabolism analysis
Recent Studies and Trials
The following peer-reviewed studies and clinical trials have investigated the properties and applications of this peptide:
Novel ERRα Inverse Agonist Discovery
Published: 2022
Exercise Mimetic Properties
Published: 2022
Metabolic Benefits Without Exercise
Published: 2022
Note: These studies are provided for informational and research purposes only. This product is not intended for human consumption.